Glatiramer Acetate used to treat multiple sclerosis. It is an immunomodulator medication. Glatiramer acetate is approved in the United States to reduce the frequency of relapses, but not for reducing the progression of disability. Reference standards of Glatiramer Acetate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Glatiramer Acetate
Catalogue No.:PA 07 48000
CAS :
Molecular Formula : C25H45N5O13
Molecular Weight : 623.65
3-Bromo-L-tyrosine
Catalogue No.:PA 07 48510
Molecular Formula : C9H10BrNO3
Molecular Weight : 260.08
Benzyl (S)-5-(((S)-1-(((S)-3-(4-hydroxyphenyl)-1-(methylamino)-1-oxopropan-2-yl)amino)-1-oxopropan-2-yl)amino)-4-((S)-2-(methylamino)-4-(2,2,2-trifluoroacetamido)butanamido)-5-oxopentanoate
Catalogue No.:PAI 07 008010
Molecular Formula : C32H41F3N6O8
Molecular Weight : 694.71
(S)-5-(((S)-1-(((S)-3-(4-Hydroxyphenyl)-1-(methylamino)-1-oxopropan-2-yl)amino)-1-oxopropan-2-yl)amino)-4-((S)-2-(methylamino)-4-(2,2,2-trifluoroacetamido)butanamido)-5-oxopentanoic acid
Catalogue No.:PAI 07 008020
Molecular Formula : C25H35F3N6O8
Molecular Weight : 604.58
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
